Physician profile

Barbara Jean Guillette

Otolaryngology · Warwick, RI

NPI 1871656611

$3,848.97

in general payments reported to CMS, 2019-2025

26 companies · none reported in 2025

See the full distribution for Otolaryngology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$354.66

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Optinose US, INC. $574.63 2019-2023
Astrazeneca Pharmaceuticals LP $534.25 2019-2022
Glaxosmithkline, LLC. $481.65 2020-2024 Nucala
Regeneron Healthcare Solutions, INC. $466.34 2019-2024 Dupixent
Genzyme Corporation $259.44 2019-2023
Abbvie INC. $217.30 2021-2022
Biohaven Pharmaceutical Holding Company LTD. $176.59 2022
Novartis Pharmaceuticals Corporation $165.01 2019-2023
Boehringer Ingelheim Pharmaceuticals, INC. $162.28 2019
Amgen INC. $95.92 2019
Stryker Corporation $80.78 2022
Kaleo, INC. $78.72 2019-2020
Pfizer INC. $77.30 2023-2024
Genentech USA, INC. $76.49 2020-2021
Biohaven Pharmaceuticals, INC. $68.63 2020-2021
Show all 26 companies
CompanyGeneral paymentsYearsTop products
Alk-Abello, INC $51.66 2019-2020
Smith+Nephew, INC. $49.58 2019
Pharming Healthcare, INC. $43.52 2022
Aerin Medical INC. $42.32 2019-2021
Teva Pharmaceuticals USA, INC. $36.57 2022
Mylan Pharmaceuticals INC. $27.06 2020
Acclarent, INC $22.89 2019
Inspire Medical Systems, INC. $17.38 2023 Inspire
Greer Laboratories, INC. $16.44 2019
Watermark Medical, INC. $14.14 2024
Eyevance Pharmaceuticals LLC $12.08 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Barbara Jean Guillette

$3,848.97

in general payments reported 2019-2025

Years
2019-2024
Top company
Optinose US, INC.

https://glasscript.com/doctor/130853/barbara-jean-guillette

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.